‘Armored’ CAR T Cells Show Early Promise in Relapsed B-Cell ALL

By News Health
2 hours Ago

(MedPage Today) — At the recent American Society of Hematology annual meeting, phase I data highlighted a next-generation, CD19-targeted, interleukin-18-secreting “armored” CAR T-cell therapy that is designed to enhance persistence and antileukemic…

Source link : https://www.medpagetoday.com/meetingcoverage/ashvideopearlsall/119164

Author :

Publish date : 2025-12-23 17:16:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

The Midterms Are Coming. Vaccines May Play a Role.

Six-Monthly HIV Prevention Injection Cleared by MHRA

Long-Term Tofersen Use May Slow ALS Progression, 3-Year Data Suggest

FDA Approves First Oral Medication for Iron Deficiency in Kids

Blood-Based Immune Markers May Predict Response to Preoperative Therapy in TNBC

Reassuring Findings for Use of Common Sleep Medications in Pregnancy